EDITORIALS

Signaling Inhibitors in the Clinic: New Agents and New Challenges

Gary Hudes

JCO Apr 1 1999: 1093. [Full Text] [PDF]

PHASE I AND CLINICAL PHARMACOLOGY
	Phase I and Pharmacologic Study of the Tyrosine Kinase Inhibitor SU101 in Patients With Advanced Solid Tumors
	S. Gail Eckhardt, Jinee Rizzo, Kevin R. Sweeney, Gillian Cropp, Sharyn D. Baker, John G. Kuhn, Miguel A. Villalona-Calero, Lisa Hammond, Geoffrey Weiss, Allison Thurman, Lon Smith, Ronald Drengler, John R. Eckardt, Judy Moczygemba, Alison L. Hannah, Daniel D. Von Hoff, and Eric K. Rowinsky
	JCO Apr 1 1999: 1095. [Abstract] [Full Text] [PDF]

GASTROINTESTINAL CANCER
	Correlation Between Uracil and Dihydrouracil Plasma Ratio, Fluorouracil (5-FU) Pharmacokinetic Parameters, and Tolerance in Patients With Advanced Colorectal Cancer: A Potential Interest for Predicting 5-FU Toxicity and Determining Optimal 5-FU Dosage
	E. Gamelin, M. Boisdron-Celle, V. Guérin-Meyer, R. Delva, A. Lortholary, F. Genevieve, F. Larra, N. Ifrah, and J. Robert
	JCO Apr 1 1999: 1105. [Abstract] [Full Text] [PDF]
	Efficacy and Safety of Prolonged-Release Lanreotide in Patients With Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms
	A.N.M. Wymenga, B. Eriksson, P.I. Salmela, M.B. Jacobsen, E.J.D.G. Van Cutsem, R.H. Fiasse, M.J. Välimäki, J. Renstrup, E.G.E. de Vries, and K.E. Öberg
	JCO Apr 1 1999: 1111. [Abstract] [Full Text] [PDF]

BREAST CANCER
	5-Year Results of Dose-Intensive Sequential Adjuvant Chemotherapy for Women With High-Risk Node-Positive Breast Cancer: A Phase II Study
	C. Hudis, M. Fornier, L. Riccio, D. Lebwohl, J. Crown, T. Gilewski, A. Surbone, V. Currie, A. Seidman, B. Reichman, M. Moynahan, G. Raptis, N. Sklarin, M. Theodoulou, L. Weiselberg, R. Salvaggio, K.S. Panageas, T.J. Yao, and L. Norton
	JCO Apr 1 1999: 1118. [Abstract] [Full Text] [PDF]
	Docetaxel: Standard Recommended Dose of 100 mg/m2 Is Effective But Not Feasible for Some Metastatic Breast Cancer Patients Heavily Pretreated With Chemotherapy—A Phase II Single-Center Study
	E. Salminen, M. Bergman, S. Huhtala, and E. Ekholm
	JCO Apr 1 1999: 1127. [Abstract] [Full Text] [PDF]
	Comparative Effects of Paclitaxel and Docetaxel on the Metabolism and Pharmacokinetics of Epirubicin in Breast Cancer Patients
	M. Esposito, M. Venturini, M.O. Vannozzi, G. Tolino, G. Lunardi, O. Garrone, C. Angiolini, M. Viale, M. Bergaglio, L. Del Mastro, and R. Rosso
	JCO Apr 1 1999: 1132. [Abstract] [Full Text] [PDF]

GYNECOLOGIC CANCER
	Clinical Features of Hypersensitivity Reactions to Carboplatin
	Maurie Markman, Alexander Kennedy, Kenneth Webster, Paul Elson, Gertrude Peterson, Barbara Kulp, and Jerome Belinson
	JCO Apr 1 1999: 1141. [Abstract] [Full Text] [PDF]

GENITOURINARY CANCER
	Optimal Planning Target Volume for Stage I Testicular Seminoma: A Medical Research Council Randomized Trial
	S.D. Fosså, A. Horwich, J.M. Russell, J.T. Roberts, M.H. Cullen, N.J. Hodson, W.G. Jones, H. Yosef, G.M. Duchesne, J.R. Owen, E.J. Grosch, A.D. Chetiyawardana, N.S. Reed, B. Widmer, and S.P. Stenning
	JCO Apr 1 1999: 1146. [Abstract] [Full Text] [PDF]
	Consensus Statements on Radiation Therapy of Prostate Cancer: Guidelines for Prostate Re-Biopsy After Radiation and for Radiation Therapy With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy
	JCO Apr 1 1999: 1155. [Abstract] [Full Text] [PDF]

SARCOMAS
	Combined Modality Treatment for Osteosarcoma Occurring as a Second Malignant Disease
	Stefan S. Bielack, Beate Kempf-Bielack, Ulrich Heise, Dorothea Schwenzer, and Kurt Winkler
	JCO Apr 1 1999: 1164. [Abstract] [Full Text] [PDF]

LUNG CANCER
	Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome
	Anthony Elias, Joseph Ibrahim, Arthur T. Skarin, Catherine Wheeler, Mary McCauley, Lois Ayash, Paul Richardson, Lowell Schnipper, Karen H. Antman, and Emil Frei, III
	JCO Apr 1 1999: 1175. [Abstract] [Full Text] [PDF]
	Impact of Preoperative Bimodality Induction Including Twice-Daily Radiation on Tumor Regression and Survival in Stage III Non–Small-Cell Lung Cancer
	Michael Thomas, Christian Rübe, Michael Semik, Michael von Eiff, Lutz Freitag, Hans N. Macha, Wolfgang Wagner, Folker Klinke, Hans H. Scheld, Norman Willich, Wolfgang E. Berdel, and Klaus Junker
	JCO Apr 1 1999: 1185. [Abstract] [Full Text] [PDF]
	Multitargeted Antifolate LY231514 as First-Line Chemotherapy for Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study
	James J. Rusthoven, Elizabeth Eisenhauer, Charles Butts, Richard Gregg, Janet Dancey, Bryn Fisher, and Jose Iglesias
	JCO Apr 1 1999: 1194. [Abstract] [Full Text] [PDF]

PEDIATRIC ONCOLOGY
	Which Cases Are Found and Missed by Neuroblastoma Screening at 1 Year? Results From the 1992 to 1995 Study in Three Federal States of Germany
	F. Berthold, A. Baillot, B. Hero, P. Schurr, A. Nerenz, D.H. Hunneman, and J. Sander
	JCO Apr 1 1999: 1200. [Abstract] [Full Text] [PDF]
	Indium-111–Antimyosin Scintigraphy in the Early Detection of Heart Damage After Anthracycline Therapy in Children
	L.C.M. Kremer, M.M.C. Tiel-van Buul, M.C. Ubbink, M. Offringa, J. Ottenkamp, R. Valdés Olmos, and P.A. Voûte
	JCO Apr 1 1999: 1208. [Abstract] [Full Text] [PDF]
	Prognostic Factors in Children With Localized Malignant Nonseminomatous Germ Cell Tumors
	M. C. Baranzelli, A. Kramar, E. Bouffet, E. Quintana, H. Rubie, C. Edan, and C. Patte
	JCO Apr 1 1999: 1212. [Abstract] [Full Text] [PDF]
	Role of Adjuvant Chemotherapy in the Treatment of Surgically Resected Pediatric Nonrhabdomyosarcomatous Soft Tissue Sarcomas: A Pediatric Oncology Group Study
	Charles B. Pratt, Alberto S. Pappo, Peter Gieser, Jesse J. Jenkins, James Neff, Bhaskar Rao, Dan Green, Patrick Thomas, Robert Marcus, David Parham, and Harold Maurer
	JCO Apr 1 1999: 1219. [Abstract] [Full Text] [PDF]

HEMATOLOGIC MALIGNANCIES
	Effect of CD34+ Cell Dose on Resource Utilization in Patients After High-Dose Chemotherapy With Peripheral-Blood Stem-Cell Support
	Kevin A. Schulman, Robert Birch, Bo Zhen, Neelima Pania, and Charles H. Weaver
	JCO Apr 1 1999: 1227. [Abstract] [Full Text] [PDF]
	Graft-Versus-Tumor Induction With Donor Leukocyte Infusions as Primary Therapy for Patients With Malignancies
	David L. Porter, Jean M. Connors, Vivianna M.D. Van Deerlin, Kathleen M. Duffy, Carol McGarigle, Susan L. Saidman, Debra G.B. Leonard, and Joseph H. Antin
	JCO Apr 1 1999: 1234. [Abstract] [Full Text] [PDF]
	Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
	Bruce D. Cheson, Sandra J. Horning, Bertr Coiffier, Margaret A. Shipp, Richard I. Fisher, Joseph M. Connors, T. Andrew Lister, Julie Vose, Antonio Grillo-López, Anton Hagenbeek, Fernando Cabanillas, Donald Klippensten, Wolfgang Hiddemann, Ronald Castellino, Nancy L. Harris, James O. Armitage, William Carter, Richard Hoppe, and George P. Canellos
	JCO Apr 1 1999: 1244. [Abstract] [Full Text] [PDF]
	Nongastrointestinal Low-Grade Mucosa-Associated Lymphoid Tissue Lymphoma: Analysis of 75 Patients
	Pier Luigi Zinzani, Massimo Magagnoli, Piero Galieni, Maurizio Martelli, Venerino Poletti, Francesco Zaja, Stefano Molica, Alfonso Zaccaria, Anna Maria Cantonetti, Patrizia Gentilini, Luciano Guardigni, Filippo Gherlinzoni, Michela Ribersani, Maurizio Bendandi, Patrizia Albertini, and Sante Tura
	JCO Apr 1 1999: 1254. [Abstract] [Full Text] [PDF]
	Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease
	Kim E. Nichols, Seth Levitz, Kristen E. Shannon, Doke C.R. Wahrer, Daphne W. Bell, Gloria Chang, Sanjay Hegde, Donna Neuberg, Timothy Shafman, Nancy J. Tarbell, Peter Mauch, Chikashi Ishioka, Daniel A. Haber, and Lisa Diller
	JCO Apr 1 1999: 1259. [Abstract] [Full Text] [PDF]

COST EFFECTIVENESS
	Totally Implantable Venous Access Ports Systems for Patients Receiving Chemotherapy for Solid Tissue Malignancies: A Randomized Controlled Clinical Trial Examining the Safety, Efficacy, Costs, and Impact on Quality of Life
	Eric J. Bow, Marilyn G. Kilpatrick, and Jennifer J. Clinch
	JCO Apr 1 1999: 1267. [Abstract] [Full Text] [PDF]
	Stability of Attitudes Regarding Physician-Assisted Suicide and Euthanasia Among Oncology Patients, Physicians, and the General Public
	Joanne Wolfe, Diane L. Fairclough, Brian R. Clarridge, Elisabeth R. Daniels, and Ezekiel J. Emanuel
	JCO Apr 1 1999: 1274. [Abstract] [Full Text] [PDF]
	Empirical Comparison of Commonly Used Measures to Evaluate Pain Treatment in Cancer Patients With Chronic Pain
	Rianne de Wit, Frits van Dam, Huda Huijer Abu-Saad, Simone Loonstra, Linda Zandbelt, Anneke van Buuren, Karin van der Heijden, and Gerleen Leenhouts
	JCO Apr 1 1999: 1280. [Abstract] [Full Text] [PDF]
	Erythropoietin Addition to Granulocyte Colony-Stimulating Factor Abrogates Life-Threatening Neutropenia and Increases Peripheral-Blood Progenitor-Cell Mobilization After Epirubicin, Paclitaxel, and Cisplatin Combination Chemotherapy: Results of a Randomized Comparison
	Luca Pierelli, Alessandro Perillo, Stefano Greggi, Giovanna Salerno, Pierluigi Benedetti Panici, Giacomo Menichella, Andrea Fattorossi, Giuseppe Leone, Salvatore Mancuso, and Giovanni Scambia
	JCO Apr 1 1999: 1288. [Abstract] [Full Text] [PDF]
	Comparative Effects of Three Cytokine Regimens After High-Dose Cyclophosphamide: Granulocyte Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), and Sequential Interleukin-3 and GM-CSF
	Alberto Ballestrero, Fabio Ferrando, Anna Garuti, Palma Basta, Roberta Gonella, Paola Stura, Giuseppe Sandro Mela, Mario Sessarego, Marco Gobbi, and Franco Patrone
	JCO Apr 1 1999: 1296. [Abstract] [Full Text] [PDF]
	Hickman Catheter–Related Infections in Neutropenic Patients: Insertion in the Operating Theater Versus Insertion in the Radiology Suite
	Jan L. Nouwen, Jenne J. Wielenga, Hans van Overhagen, J. S. Laméris, Jan A.J.W. Kluytmans, Myra D. Behrendt, Wim C.J. Hop, Henri A. Verbrugh, and Simon de Marie
	JCO Apr 1 1999: 1304. [Abstract] [Full Text] [PDF]

ASCO SPECIAL ARTICLES
	Recommended Colorectal Cancer Surveillance Guidelines by the American Society of Clinical Oncology
	Christopher E. Desch, Al B. Benson, III, Thomas J. Smith, Patrick J. Flynn, Carol Krause, Charles L. Loprinzi, Bruce D. Minsky, Nicholas J. Petrelli, David G. Pfister, and Mark R. Somerfield
	JCO Apr 1 1999: 1312. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Lethal Midline Granuloma Revisited: Nasal T/Natural-Killer Cell Lymphoma

C. S. Chim, G. C. Ooi, T. W.H. Shek, R. Liang, and Y. L. Kwong

JCO Apr 1 1999: 1322. [Full Text] [PDF]

CORRESPONDENCE

Should We Delay Prostate Radiotherapy?

John P. Petersen, Paul F. Schellhammer, Michael J. Zelefsky, and Steven A. Leibel

JCO Apr 1 1999: 1326. [Full Text] [PDF]

JCO Apr 1 1999: 1326a. [PDF]

JCO Apr 1 1999: 1326b. [PDF]

JCO Apr 1 1999: 1326c. [PDF]

SPECIAL DEPARTMENTS

ERRATA

Correction for vol. 17, p. 870

JCO Apr 1 1999: 1330. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.